121 related articles for article (PubMed ID: 38492258)
41. [A case of sarcomatoid renal cell carcinoma associated with giant hydronephrosis].
Kimura R; Koyama K; Abe H
Hinyokika Kiyo; 2012 Aug; 58(8):435-8. PubMed ID: 23052269
[TBL] [Abstract][Full Text] [Related]
42. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
43. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
44. Ureteral tumours showing a worse prognosis than renal pelvis tumours may be attributed to ureteral tumours more likely to have hydronephrosis and less likely to have haematuria.
Zhang X; Zhu Z; Zhong S; Xu T; Shen Z
World J Urol; 2013 Feb; 31(1):155-60. PubMed ID: 22614444
[TBL] [Abstract][Full Text] [Related]
45. Lymph node metastasis in patients with carcinomas of the renal pelvis and ureter.
Miyao N; Masumori N; Takahashi A; Sasai M; Hisataki T; Kitamura H; Satoh M; Tsukamoto T
Eur Urol; 1998; 33(2):180-5. PubMed ID: 9519361
[TBL] [Abstract][Full Text] [Related]
46. Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?
Terada T
Int J Clin Exp Pathol; 2013; 6(4):724-8. PubMed ID: 23573320
[TBL] [Abstract][Full Text] [Related]
47. Chromophobe Renal Cell Carcinoma: Results From a Large Single-Institution Series.
Casuscelli J; Becerra MF; Seier K; Manley BJ; Benfante N; Redzematovic A; Stief CG; Hsieh JJ; Tickoo SK; Reuter VE; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
Clin Genitourin Cancer; 2019 Oct; 17(5):373-379.e4. PubMed ID: 31326335
[TBL] [Abstract][Full Text] [Related]
48. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
[TBL] [Abstract][Full Text] [Related]
49. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
50. [Clinicopathologic study of renal cell carcinoma with rhabdoid features].
Ma J; Zhou XJ; Huang WB; Zhou HB; Jiang SJ; Rao Q; Lu ZF; Shi QL
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):166-70. PubMed ID: 17535682
[TBL] [Abstract][Full Text] [Related]
51. Pathological risk factors in upper urinary tract cancer.
Shimamoto T; Inoue K; Kamata M; Kuno T; Karashima T; Shuin T
Asia Pac J Clin Oncol; 2016 Mar; 12(1):e179-88. PubMed ID: 24289213
[TBL] [Abstract][Full Text] [Related]
52. The role of percutaneous needle biopsy in differentiation of renal tumors.
Izumi K; Narimoto K; Sugimoto K; Kobori Y; Maeda Y; Mizokami A; Koh E; Yamada T; Yano S; Namiki M
Jpn J Clin Oncol; 2010 Nov; 40(11):1081-6. PubMed ID: 20601495
[TBL] [Abstract][Full Text] [Related]
53. Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease.
Molina AM; Tickoo SK; Ishill N; Trinos MJ; Schwartz LH; Patil S; Feldman DR; Reuter VE; Russo P; Motzer RJ
Am J Clin Oncol; 2011 Oct; 34(5):454-9. PubMed ID: 21127411
[TBL] [Abstract][Full Text] [Related]
54. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
55. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
[TBL] [Abstract][Full Text] [Related]
56. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome.
Cheville JC; Lohse CM; Zincke H; Weaver AL; Leibovich BC; Frank I; Blute ML
Am J Surg Pathol; 2004 Apr; 28(4):435-41. PubMed ID: 15087662
[TBL] [Abstract][Full Text] [Related]
57. Renal cell carcinoma invading the urinary collecting system: implications for staging.
Uzzo RG; Cherullo E; Myles J; Novick AC
J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
[TBL] [Abstract][Full Text] [Related]
58. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection.
Pantuck AJ; Zisman A; Dorey F; Chao DH; Han KR; Said J; Gitlitz BJ; Figlin RA; Belldegrun AS
J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723
[TBL] [Abstract][Full Text] [Related]
59. Influence of preoperative hydronephrosis on the outcome of urothelial carcinoma of the upper urinary tract after nephroureterectomy: the results from a multi-institutional French cohort.
Bozzini G; Nison L; Colin P; Ouzzane A; Yates DR; Audenet F; Pignot G; Arvin-Berod A; Merigot O; Guy L; Irani J; Saint F; Gardic S; Gres P; Rozet F; Neuzillet Y; Ruffion A; Roupret M
World J Urol; 2013 Feb; 31(1):83-91. PubMed ID: 23064982
[TBL] [Abstract][Full Text] [Related]
60. [Clinicopathological characteristics of fumarate hydratase-deficient renal cell carcinoma].
Zhang W; Chu J; Zou YW; Jiang YX; Wei ZM; Zhong DC; Liu Y; Li YJ; Yu WJ
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):120-126. PubMed ID: 30695864
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
